Medicrea International

Equities

ALMED

FR0004178572

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.58%	+134.69%

2020	Covidien Group S.a.r.l. completed the acquisition of 96.7% stake in Medicrea International SA.	CI
2020	Medicrea International SA Announces Sales Results for the Third Quarter and Year to Date Ended September 30, 2020	CI

Medicrea Group Reports Unaudited Earnings Results for the Half Year Ended June 30, 2017

October 03, 2017 at 07:38 am EDT

Medicrea Group reported unaudited earnings results for the half year ended June 30, 2017. For the period the company reported, sales was €14,696,429 against €14,843,675 a year ago. Operating loss before non-recurring expenses was €3,553,612 against €1,492,342 a year ago. Loss before tax was €5,548,417 against €2,924,457 a year ago. Consolidated net loss was €5,120,517 against €2,670,993 a year ago. Net cash out flow from operating activities was €1,211,955.

Latest news about Medicrea International

Covidien Group S.a.r.l. completed the acquisition of 96.7% stake in Medicrea International SA.	20-11-04	CI
Medicrea International SA Announces Sales Results for the Third Quarter and Year to Date Ended September 30, 2020	20-10-08	CI
Medtronic : to Buy Medicrea International for $154 Million	20-07-15	DJ
Covidien Group S.a.r.l. entered into a tender offer agreement to acquire 96.7% stake in Medicrea International SA for approximately €140 million.	20-07-14	CI
The MEDICREA Group Reports Sales Results for the Month and First Half Ended June 2020	20-07-09	CI
Medicrea International SA Reports Sales Results for the First Quarter and Year to Date Ended March 15, 2020	20-04-10	CI
MEDICREA® Announces FDA Clearance of the First Patient-Matched Spinal Interbody Cages	20-02-11	CI
Medicrea International Sa Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-13	CI
Medicrea International SA Announces Sales Results for the Third Quarter and Nine Months Ended on September 30, 2019	19-10-11	CI
Medicrea Reports Earnings Results for the Half Year Ended June 30, 2019	19-09-19	CI
The MEDICREA® Group Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI Platform Technology	19-08-02	CI
The Medicrea Group Reports Sales Results for the First Half 2019	19-07-09	CI
The Medicrea Group Reports Unaudited Earnings Results for the First Quarter of 2019	19-05-17	CI
The MEDICREA Group Enhances Proprietary UNiD ASI Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service	19-04-18	CI
Medicrea International SA Reports Sales Results for the First Quarter of 2019	19-04-10	CI
Medicrea International SA Announces Earnings Results for the Year 2018	19-03-22	CI
The Medicrea Group Reports Sales Results for the Fourth Quarter and Full Year of 2018	19-01-16	CI
Medicrea International SA announced that it has received $30 million in funding from Perceptive Credit Holdings II, LP	18-11-26	CI
The Medicrea Group Reports Unaudited Earnings Results for the Third Quarter and Year to Date Ended Sep. 2018	18-11-15	CI
Medicrea International SA Announces Sales Results for the Third Quarter and Year to Data Ended September 30, 2018	18-10-11	CI
The Medicrea Group Announces the Publication of New Study Validating the Use of UNiD Patient-Specific Rods	18-10-10	CI
Certain Ordinary Shares of Medicrea International SA are subject to a Lock-Up Agreement Ending on 10-OCT-2018.	18-10-09	CI
Medicrea International SA Reports Unaudited Earnings Results for the First Half of 2018	18-09-19	CI
Medicrea Group Signs A Joint-Venture Agreement with the Spine Division of National Surgical Pty Ltd; Appoints Jon Mills as Head of New Subsidiary	18-07-10	CI
The Medicrea Group Announces Sales Results for the Month, Quarter and Six Months Ended June 2018; Provides Earnings Guidance for the Full Year of Fiscal 2018	18-07-05	CI

Chart Medicrea International

Duration

Period

More charts

Company Profile

Medicrea International SA is a France-based company that specializes in the design and manufacture of medical devices. The Company design, integrated manufacturing and distribution of implantable devices designed to treat spinal pathologies. It provides digital transformation of spine surgery. It developed UNiD ASI (Adaptive Spine Intelligence) technology implementing Artificial Intelligence, Predictive Modeling and Personalized Spinal Implants. The Company strengthen efficiency spine treatments by reducing surgical complications and limiting the time spent in the operating room with a view to predictive medicine.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Medical Devices & Implants

	1st Jan change	Capi.
MEDICREA INTERNATIONAL	+134.69%	182M
STRYKER CORPORATION	+11.20%	127B
SMITH & NEPHEW PLC	-5.10%	11.32B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.04B
GLAUKOS CORPORATION	+37.11%	5.56B
INSPIRE MEDICAL SYSTEMS, INC.	-23.72%	4.72B
AXONICS, INC.	+8.55%	3.45B
ENOVIS CORPORATION	-6.46%	2.86B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.07B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.04B

Medical Devices & Implants